Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria-Reference-Cited by-同舟云学术

Potentially inappropriate prescribing among older patients and associated factors: comparison of two versions of STOPP/START criteria

Published:2023 Issue: Volume:59 Page:
ISSN:2175-9790
Container-title:Brazilian Journal of Pharmaceutical Sciences
language:
Short-container-title:Braz. J. Pharm. Sci.

Author:

Jovanović Marija¹,Kovačević Milena¹^ORCID,Catić-Đorđević Aleksandra²,Ćulafić Milica¹,Stefanović Nikola²,Mitić Branka³,Vučićević Katarina¹,Kovačević Sandra Vezmar¹,Veličković-Radovanović Radmila³,Miljković Branislava¹

Affiliation:

1. University of Belgrade, Republic of Serbia

2. University of Niš, Republic of Serbia

3. University of Niš, Republic of Serbia; University Clinical Center Niš, Republic of Serbia

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S1984-82502023000100391&tlng=en

Reference40 articles.

1. 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2022;Diabetes care,2022

2. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors;Anrys PMS;J Am Med Dir Assoc,2018

3. Explicit criteria for determining potentially inappropriate medication use by the elderly;Beers MH;An update. Arch Intern Med,1997

4. Assessing potentially inappropriate prescribing in community-dwelling older patients using the updated version of STOPP-START criteria: a comparison of profiles and prevalences with respect to the original version;Blanco-Reina E;PLoS One,2016

5. 2015 Beers criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: prevalence, profile, and risk factors;Blanco-Reina E;Eur J Clin Pharmacol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of potentially inappropriate medications among elderly patients with diabetes – study based on STOPP/START criteria;Pharmacia;2023-09-19